EIDP, Inc.

Listed Company

CTA-PBCIK 0000030554NYSEPlastic Material, Synth Resin/Rubber, Cellulos (No Glass)DelawareFY ends Dec 31

Period

FY 2016

Revenue

$24.59B

Net Income

$2.51B

Total Assets

$39.96B

Equity

$10.00B

Shares Out

100

Op. Cash Flow

$3.30B

Business

EIDP, Inc. is the legal entity referenced in Corteva’s filings and, following an internal reorganization, is a wholly‑owned subsidiary contributed to Corteva, Inc., supporting the company’s agriculture business. It participates in the development, supply and licensing of seed genetics, trait technologies and crop protection products and related digital agronomy and seed‑applied solutions. Operations are organized into two reportable segments: Seed (commercial seed, germplasm and trait platforms) and Crop Protection (herbicides, insecticides, fungicides, nitrogen management and biologicals). Products are sold globally across approximately 110 countries through multi‑channel distribution including direct Pioneer agency sales, regional and retail brands, and third‑party licensing and distribution.

Summary from filing dated 2025-02-14

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31
Net sales	24,594	25,130	28,406	28,998	34,812
Cost of goods sold	14,469	15,112	17,023	17,642	21,400
Other operating charges	686	459	645	1,222	1,856
Selling, general and administrative expenses	4,319	4,615	4,891	5,342	5,886
Research and development expense	1,641	1,898	1,958	2,037	2,123
Other income, net	−708	−697	−1,277	−371	498
Interest expense	370	342	377	448	464
Employee separation / asset related charges, net	552	810	476	112	493
Income from continuing operations before income taxes	3,265	2,591	4,313	2,566	3,088
Provision for income taxes on continuing operations	744	696	1,168	360	616
Income from continuing operations after income taxes	2,521	1,895	3,145	2,206	2,472
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest	4	64	491	—	—
Net income	2,525	1,959	3,636	4,862	2,780
Less: Net income attributable to noncontrolling interests	12	6	11	14	25
Net income attributable to DuPont	2,513	1,953	3,625	4,848	2,755
Basic earnings per share of common stock from continuing operations	2.86	2.1	3.42	2.36	2.61
Basic earnings per share of common stock from discontinued operations	0	0.07	0.54	2.87	0.33
Basic earnings per share of common stock	2.87	2.17	3.95	5.22	2.94
Diluted earnings per share of common stock from continuing operations	2.85	2.09	3.39	2.34	2.59
Diluted earnings per share of common stock from discontinued operations	0	0.07	0.53	2.85	0.33
Diluted earnings per share of common stock	2.85	2.16	3.92	5.18	2.91
Dividends per share of common stock	1.52	1.72	1.84	1.78	1.7

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31
Cash and Cash Equivalents	4,466	7,250	4,605	5,300	6,910
Marketable Securities	34	952	—	—	—
Accounts and notes receivable - net	5,534	5,239	4,971	4,643	5,238
Inventories	7,407	8,633	5,673	6,140	6,787
Other current assets	1,165	981	—	—	—
Total current assets	18,606	23,055	17,117	17,387	26,082
Investments in nonconsolidated affiliates	1,381	1,595	649	688	762
Property, Plant and Equipment, Gross	13,906	12,878	23,967	24,130	23,773
Accumulated Depreciation	1,720	443	14,736	14,346	13,765
Property, Plant and Equipment, Net	12,186	12,435	9,231	9,784	10,008
Goodwill	40,686	45,589	4,180	4,248	4,332
Other intangible assets	26,053	27,726	3,664	4,144	4,569
Deferred Income Taxes	303	480	—	—	—
Other Assets	1,810	2,084	1,815	1,116	1,003
Total Assets	101,025	112,964	39,964	41,166	50,490
Short-term borrowings and capital lease obligations	2,160	2,779	429	1,165	1,422
Accounts Payable	4,982	4,831	3,705	3,398	3,786
Income Taxes Payable	66	149	—	—	—
Accrued and other current liabilities	4,233	4,384	4,662	5,580	5,596
Total current liabilities	11,441	12,143	8,897	10,316	13,805
Long-term Debt	5,812	10,291	8,107	7,642	9,233
Deferred Income Tax Liabilities	5,381	5,836	—	—	—
Pension and other post employment benefits - noncurrent	6,683	7,787	—	—	—
Other noncurrent obligations	1,620	1,975	12,333	12,591	13,615
Liabilities, Noncurrent	19,496	25,889	—	—	—
Common stock, $0.30 par value; 1,800,000,000 shares authorized; issued at December 31, 2018 and December 31, 2017 100	0	0	285	288	298
Additional Paid in Capital	79,790	74,727	—	—	—
(Accumulated deficit) retained earnings	−7,669	175	14,924	14,510	16,894
Accumulated other comprehensive loss	−2,503	−381	−9,911	−9,396	−8,556
Total DuPont Stockholders' Equity	69,857	74,760	9,998	9,993	13,320
Noncontrolling Interests	231	172	198	207	58
Total Stockholders' Equity	70,088	74,932	10,196	10,200	13,378
Total Liabilities and Equity	101,025	112,964	39,964	41,166	50,490

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31
Depreciation	939	1,104	1,254	1,280	1,376
Amortization of intangible assets	319	362	363	323	337
Net periodic pension benefit cost	572	591	406	953	832
Contributions to pension plans	−535	−308	−311	−313	−848
Gain on sales of business and other assets	436	59	726	—	—
Asset related charges	682	147	174	—	—
Other operating activities - net	366	106	192	170	353
Accounts and notes receivable	−270	−448	−88	−976	114
Inventories and other operating assets	−54	164	−318	−519	−812
Accounts payable and other operating liabilities	−704	−1,063	−1,064	240	1,037
Accrued interest and income taxes	−104	−239	194	−154	−320
Cash provided by operating activities	3,300	2,316	3,712	3,179	4,849
Purchases of property, plant and equipment	−1,019	−1,629	−2,020	−1,882	−1,793
Investments in affiliates	−19	−76	−42	−58	−97
Payments for businesses - net of cash acquired	0	−152	0	−133	−18
Proceeds from sale of businesses and other assets - net	316	156	1,092	—	—
Purchases of short-term financial instruments	−2,633	−1,897	−936	−497	−650
Proceeds from maturities and sales of short-term financial instruments	2,181	1,121	950	452	965
Foreign currency exchange contract settlements	−385	615	430	40	−40
Other investing activities - net	45	34	189	40	−15
Cash (used for) provided by for investing activities	−1,514	−1,828	−337	2,945	−1,346
Dividends paid to stockholders	−1,335	−1,546	−1,696	−1,661	−1,594
Net increase (decrease) in short-term (less than 90 days) borrowings	387	−1	−11	16	−200
Receipts	813	3,679	104	2,013	323
Payments	−1,440	−1,537	−1,794	−1,312	−916
Repurchase of common stock	−916	−2,353	−2,000	−1,000	−400
Proceeds from exercise of stock options	181	274	327	536	550
Cash transferred to Chemours at spin-off	0	−250	0	0	—
Other financing activities - net	−18	−89	−4	−1	10
Cash used for financing activities	−2,328	−1,823	−5,074	−1,474	−2,697
Effect of exchange rate changes on cash	−153	−275	−332	−88	−13
(Decrease) increase in cash and cash equivalents	−695	−1,610	−2,031	4,562	698
Interest, net of amounts capitalized	386	341	394	489	501
Income taxes	735	885	1,016	1,323	1,054

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro